18F-FDG-PET/CT in malignant mesothelioma

Chiara Fuccio, Elena Giulia Spinapolice, Alice Ferretti, Paolo Castellucci, Maria Cristina Marzola, Giuseppe Trifirò, Domenico Rubello

Research output: Contribution to journalArticlepeer-review


It is well known the useful role of 18F-FDG-PET/CT for differential diagnosis between benign and malignant disease, for staging, for monitoring response and for prognosis regarding mesothelioma. Recently, literature was enriched with new interesting studies regarding the potential applications of 18F-FDG-PET/CT in this field. The purpose of this review is to evaluate articles published on line (PubMed) from January 2011 until October 2012 in order to obtain an overview of recent progress of molecular imaging in malignant mesothelioma. The main topics concern the use of 18F-FDG-PET/CT in radiation therapy planning, monitoring of treatment (surgery/chemotherapy) response and prognosis assessment.

Original languageEnglish
Pages (from-to)539-542
Number of pages4
JournalBiomedicine and Pharmacotherapy
Issue number6
Publication statusPublished - Jul 2013


  • Malignant mesothelioma
  • Prognosis
  • Radiation therapy planning
  • Treatment response

ASJC Scopus subject areas

  • Pharmacology
  • Medicine(all)


Dive into the research topics of '18F-FDG-PET/CT in malignant mesothelioma'. Together they form a unique fingerprint.

Cite this